Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview

William "Bill" Ackman, founder and chief executive officer of Pershing Square Capital Management LP, speaks during a Bloomberg Television interview in New York, U.S., on Wednesday, April 23, 2014. Ackman already has a $1 billion paper gain on a newly disclosed 9.7 percent stake in Allergan Inc., helping to offset losses that his funds incurred through an earlier bet against Herbalife Ltd. Photographer: Scott Eells/Bloomberg via Getty Images
William "Bill" Ackman, founder and chief executive officer of Pershing Square Capital Management LP, speaks during a Bloomberg Television interview in New York, U.S., on Wednesday, April 23, 2014. Ackman already has a $1 billion paper gain on a newly disclosed 9.7 percent stake in Allergan Inc., helping to offset losses that his funds incurred through an earlier bet against Herbalife Ltd. Photographer: Scott Eells/Bloomberg via Getty Images
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
EINE LIZENZ KAUFEN
Wie darf ich dieses Bild verwenden?
475,00 €
EUR

DETAILS

Einschränkungen:
Bei kommerzieller Verwendung sowie für verkaufsfördernde Zwecke kontaktieren Sie bitte Ihr lokales Büro.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Bildnachweis:
Bloomberg / Kontributor
Redaktionell #:
486251535
Kollektion:
Bloomberg
Erstellt am:
23. April 2014
Hochgeladen am:
Lizenztyp:
Releaseangaben:
Kein Release verfügbar. Weitere Informationen
Quelle:
Bloomberg
Objektname:
VALEANT PERSHING